10th August 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • Triple-dose regimen may permanently clear HIV in infected newborns
    on August 10, 2026 at 9:00 am

    Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon Health & Science University suggests another possibility: a one-time regimen of therapies given to newborns within three days of birth to permanently clear the virus. The research is published today in the journal Nature Microbiology.

  • Molecular mapping reveals hidden cellular programs in heart transplant rejection
    on August 10, 2026 at 9:00 am

    A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine approaches to treat organ rejection.

  • Prostate cancer prognosis linked to prostate-specific antigen levels below threshold
    on August 10, 2026 at 7:10 am

    After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published online in CANCER.

  • Low-fat vegan diet cuts dietary energy density by nearly a third, helping explain weight loss
    on August 9, 2026 at 3:40 pm

    A low-fat vegan diet lowers the energy density of the foods people eat by roughly 30%, allowing them to eat satisfying amounts of food while taking in fewer calories and losing weight—without deliberately restricting calories—according to new research published in JAMA Network Open.

  • New study finds bacterial infections affect about 1 in 20 hospitalized adults with firearm injuries
    on August 9, 2026 at 1:40 pm

    A new study by researchers at the University of Maryland School of Medicine (UMSOM) found that bacterial infections develop in approximately 5% of adults hospitalized with firearm injuries, with most infections occurring during the initial hospitalization rather than after patients return home. The findings were published in JAMA Network Open as a research letter.